PRO/AH/EDR> COVID-19 update (202): AstraZeneca, CIDRAP, US delta variant, WHO, global

COVID-19 — Worldwide/Unknown
A study of 5.4 million Scottish adults has revealed a small increased risk of an autoimmune bleeding disorder after the 1st dose of the AstraZeneca/Oxford COVID-19 vaccine, although a causal link hasn’t been established.
The study, led by University of Edinburgh researchers and published today [Wed 9 Jun 2021] in Nature Medicine, assessed the risk of bleeding-related events among 2.53 million people (57.5% of the population of Scotland 18 and older) up to 27 days after the 1st dose of the